Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744952 · ClinicalTrials.gov registry record
Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis
A clinical trial, sponsored by Peter Merkel.
- Completed
- Registry status
- 26
- Enrollment target
NCT00744952 is a clinical trial that has completed, run by Peter Merkel. The registered enrollment target is 26 participants.
The verdict
NCT00744952 has completed, sponsored by Peter Merkel.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Assessing disease activity in people with Takayasu's arteritis is difficult, as most people with the disease do not exhibit visible, measurable symptoms. Combination positron emission tomography/computed axial tomography (PET/CT) is a particularly sensitive, accurate scanning method that may improve researchers' ability to evaluate people with the disease. This study will determine the effectiveness of PET/CT in assessing disease activity in people with Takayasu's arteritis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-08 |
| Est. Completion | 2018-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00744952
The ClinicalTrials.gov registry entry for NCT00744952 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peter Merkel, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00744952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00744952 about?
NCT00744952 is a clinical study titled "Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis". Assessing disease activity in people with Takayasu's arteritis is difficult, as most people with the disease do not exhibit visible, measurable symptoms. Combination positron emission tomography/computed axial tomography (PET/CT) is a particularly sensitive, accurate scanning method that may improve...
What is the current status of trial NCT00744952?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-08. Estimated completion is 2018-09-30.
Who is sponsoring clinical trial NCT00744952?
This trial is sponsored by Peter Merkel, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.